期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

老年急性髓细胞白血病临床和治疗的特殊问题 被引量：3

下载PDF
导出
摘要 急性髓细胞白血病(AML)是一类尤其容易发生于老年人的疾病,且发病率随年龄的增长而递增。随着近年关于AML细胞遗传学、分子异常研究的进展及治疗靶点的识别,已极大地推动了个体化治疗、靶向治疗及新药研发,明显提高了AML的临床疗效。本文就老年急性髓细胞白血病临床和治疗的特殊问题做一述评。
作者 孔佩艳 曾东风 李杰平
机构地区 全军血液病治疗中心.第三军医大学新桥医院血液科
出处 《西部医学》 2012年第11期2047-2048,共2页 Medical Journal of West China
基金 重庆市医学重点学科项目资助(编号:2006c028) 第三军医大学新桥医院"1130"人才工程培养资金资助(编号:2012)
关键词 急性髓细胞白血病 老年 临床 治疗 预后
分类号 R733.71 [医药卫生—肿瘤]
  • 相关文献

参考文献4

  • 1COLITA Andrei, COLITA Anea, BERBEC NM. et al. Particu- lar clinical and therapeutical aspects in acute myeloid leukemia in elderly patient[J].Maedica/A Journal of Clinical Medicine, 2011,6(4) :287-289.
  • 2张冰,张东华.老年急性髓细胞白血病的治疗策略与进展[J].医学综述,2011,17(6):883-886. 被引量：8
  • 3Dombret H, Raffoux E,Gardin C. Acute myeloid leukemia in the elderly[J Semin Oncol, 2008, 35(4) :430-438.
  • 4Dohner H, Estey E H, Amadori S, et al. Diagnosis and manage- ment of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European Leuke- mlaNet[J]. Blood, 2010,115(3):453-474.

二级参考文献20

  • 1Laubach J, Rao AV. Current and emerging strategies for the man- agement of acute myeloid leukemia in the elderly [ J ]. Oncologist, 2008,13(10) :1097-1108.
  • 2Sti~walt DL, Kopecky K J, Meshinchi S, et al. FLT3, RAS, and 33?53 mutations in elderly patients with acute myeloid leukemia [ J]. Blood ,2001,97 ( 11 ) :3589-3595.
  • 3Etienne A, Esterni B, Charbonnier A, et al. Comorbidity is an inde- pendent predictor of complete remission in elderly patients receiv- ing induction chemotherapy for acute myeloid leukemia[ J]. Canc- er,2007,109(7) :1376-1383.
  • 4Appelbaum FR, Gundacker H, Head DR, et al. Age and acute mye- loid leukemia[ J ]. Blood,2006,107 (9) :3481-3485.
  • 5Ltiwenberg B, Zittoun R, Kerkhofs H, et al. On the value of inten- sive remission-induction chemotherapy in elderly patients of 65 + years withacute myeloid leukemia: a randomized phase Ⅲstudy of the European Organizationfor Research and Treatment of Cancer Leukemia Group [ J ]. J Clin Oncol, 1989,7 (9) : 1268-1274.
  • 6Lowenberg B, Zittoun R, Kerkhofs H, et al. On the value of inten- sive remission-induction chemotherapy in elderly patients of 65 + years withacute myeloid leukemia: a randomized phase Ⅲ study of the European Organizationfor Research and Treatment of Cancer Leukemia Group [ J ]. J Clin Oncol, 1989,7 (9) : 1268-1274.
  • 7Lowenberg B, Ossenkoppele GJ, van Putten W, et al. High-Dose daunorubicin in older patients with acute myeloid leukemia[ J]. N Engl J Med,2009,361 ( 13 ) : 1235-1248.
  • 8Harousseau 3L, Wu D. The use of GM-CSF and G-CSF in the treat- ment of acute leukemias E J]. Leuk Lymphoma, 1995,18 (5/6) : 405-412.
  • 9Yamada K, Furusawa S, Saito K, et al. Concurrent use of granulo- cyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia [J]. Leukemia, 1995,9( 1 ) :10-14.
  • 10Saito K, Nakamum Y, Aoyagi M, et al. Low-dose cytarabine and aclarubicin in combination with granuloeyte colony-stimulating fac- tor( CAG regimen)for previously treated patients with relapsed or primmT resistant acute myelogenous leukemia(AML) and previous- ly untreated eldedy patients with AML, secondary AML, and refrac- tory anemia with excess blasts in transformation[J], lilt J Hematol, 2000,71 ( 3 ) :238-244.

共引文献7

同被引文献34

引证文献3

二级引证文献12

西部医学
2012年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部